Abstract Body

Background: Dyslipidaemia in untreated HIV infection is characterised by reduced high density lipoprotein cholesterol (HDL) and increased risk of cardiovascular disease (CVD). In vitro, HIV impairs monocyte cholesterol efflux (MCE) onto apolipoprotein A1 (ApoA1) via the ATP-binding cassette transporter A1 (ABCA1) potentially explaining lower HDL. We aimed to determine if MCE was inhibited in untreated HIV in vivo.

Methods: Using a novel, dynamic ex vivo assay, we compared MCE in HIV positive (HIVpos) subjects not on antiretroviral therapy (ART) and HIV negative (HIVneg) controls matched for age, gender, race, smoking and hepatitis C status. Monocytes were isolated from fasting blood and monocyte intracellular cholesterol (MIC) was measured by florescence and corrected for total cell count before and after cholesterol loading (T=0, 2, 4, 6, 24 hours post loading). MCE was calculated as a ratio of extracellular (supernatant) cholesterol to MIC (ECT: MICT) with an additional 24 hr measure in the presence of ApoA1 (ECapoA1: MICapoA1). Changes in MCE were correlated with lipids and carotid intima-media thickness (C-IMT). Data are median [IQR]. Comparisons were made using non-parametric analyses.

Results: We recruited 50 HIVpos subjects (52% homosexual, 36% heterosexual; CD4+ 410[268, 588] cells/mm3; log HIV RNA 4.01[3.52, 4.78] copies/ml) and 50 matched controls. The HIVpos group had significantly lower total, low density lipoprotein and HDL cholesterol but similar triglycerides and C-IMT (table 1). There was no significant between-group difference in fasting MIC (HIVpos 2.0 [1.6, 2.4] versus HIVneg 1.8 [1.6, 2.4] pg/cell, p=0.53) or post cholesterol loaded MIC (HIVpos 7.1 [5.5, 9.6] versus HIVneg 6.7 [5.1, 9.7], p=0.39). However, MCE was significantly and consistently greater in the HIVpos group over time (table 1). The addition of ApoA1 increased EC24:MIC24 in both groups, with no between-group difference observed. Higher HDL correlated with lower ECT: MICT ratio (T2 r=-0.41, T4 r=-0.34, T6 r=-0.28, T24 r=-0.29, all p≤0.005). Neither C-IMT nor HIV RNA correlated with MCE.

Conclusions: These data suggests that untreated HIV is characterised by enhanced rather than decreased MCE, with higher MCE correlating with lower HDL. This unexpected finding may reflect up-regulation of MCE pathways compensating for any potential negative effect of HIV on ABCA1-medicated cholesterol efflux. Further research into the pathways involved, the effects of ART and the impact of these findings on CVD pathogenesis is required.

viewer?TAG_ACTION=SECURE_FILE_DOWNLOAD&V
Table 1. Baseline Characteristics and Monocyte Cholesterol Efflux by HIV status